Here are the top headlines I found with news coming from surgical robotics, dental technology, vaccines and more. Congratulations to all involved.
🔔 Olympus has teamed up with Revival Healthcare Capital to launch a joint venture Swan EndoSurgical aimed at bringing robotics to gastrointestinal procedures.
🔔Eli Lilly is walking through the Gate, inking a deal worth up to $856 million with a biotech aiming to build out a new small-molecule drug class.  Gate Biosciences discovery engine will be used to identify small-molecule drugs that can selectively eradicate harmful extracellular proteins.
🔔Novartis is serving up $60 million to partner with Matchpoint Therapeutics in hopes of getting an oral covalent inhibitor over the line for inflammatory diseases that have been historically difficult to treat.
🔔TCG Labs Soleil has secured $400 million to boost the firm’s ability to advance its biotech portfolio companies while also expanding its R&D capabilities globally.
🔔Dispatch Bio has unveiled with $216 million and the lofty goal of creating a universal treatment for solid tumors using a new immunotherapy approach.
🔔The orthopedic implant maker Shoulder Innovations is the latest medtech to plan for a nine-figure IPO, as it looks to scale up its commercial reach, hoping to raise $100m.
🔔Dental devicemaker ZimVie to be bought by ArchiMed in $730M deal
🔔Vicebio, a London-based biotech firm specialising in the development of respiratory virus vaccines, has been acquired French pharma giant Sanofi in a deal potentially worth over £1bn.
🔔A consortium led by Nordic Capital and Permira has made an around $3 billion offer to buy all shares in Bavarian Nordic, the vaccine maker said on Monday.
===============
Newton Colmore is a specialist search firm and we connect exceptional engineering and scientific talent with impactful companies, globally.
hashtagmedicaldevices hashtagbiotechnology
hashtagdeeptech hashtagtherapeutics
hashtagdrugdiscovery hashtaghealthcare
